According to Alexander Ginsburg, director of the Gamaleya National Research Center of Epidemiology and Microbiology in Russia, the Sputnik V vaccine shields all versions of Coronavirus, including the new kind of Delta strain. "The Sputnik V vaccine is effective against all variants," Ginsburg said, adding that "none of the variants has become more epidemically significant than the original variant." According to him, new Delta versions arise… read-more
Courtesy: United News Of India
The third Phase trial of the Sputnik light, a single-dose vaccine in India has been granted permission by the Drugs Controller General of India (DCGI). A study published in The Lancet showed Sputnik light has 78.6 to 83.7% efficacy against Covid. It is higher than two shot vaccines. The CDSCO committee stated that Sputnik light is the same as Sputnik V. Its safety or immunogenicity has been previously tested.
Courtesy: The Siasat Daily
The Russian "Sputnik-V" vaccine has shown more than 90 percent effectiveness in the ongoing interim trials. According to a study by Lancet journal, Sputnik-V is effective against many variants of Covid-19. Hildegund C.J. Ertl, a vaccine scientist at Wistar Institute said that the "results are great". He also said that the Russian vaccine has proven to be one of the safest and effective vaccines in the world.
Courtesy: Washington Post
The Drug Controller General of India on June 4 approved the Serum Institute of India's request to manufacture Russian COVID-19 vaccine Sputnik-V. Adar Poonawalla-owned organisation has been granted permission to examine, test and analyse the vaccine in India. SII CEO Poonawalla thanked the Ministry of External Affairs and POTUS Joe Biden for relaxing the restrictions on vaccine manufacture. For the production, SII will join hands with… read-more
Courtesy: Zee Business
A Dubai-based travel agency has offered a 24-day trip from Delhi to Russia, where the tourists will be given two doses of Sputnik-V jab with certificate under the vaccine-tourism package. The whole trip costing Rs 1.29 lakh will also benefit the travellers with the sight-seeing around Moscow and St Petersburg. The package includes tickets, meals and 3-star hotel accommodation. However, interested travellers will have to pay Rs 10,000 as visa… read-more
Courtesy: India .com
In a plea that came up on May 18, the Delhi HC slammed the Centre for being negligent towards the collaboration and procurement of COVID-19 vaccines from foreign countries. Reportedly, the Centre is due to release funds for an Indian pharmaceutical company that collaborated with Russia's Sputnik vaccine manufacturers. HC said that the Central leaders are living in 'ivory towers' without knowing the ground reality of COVID-19 impact.
Courtesy: Times Of India
The Dr. Reddy's Laboratories on May 14 rolled out the Russian COVID-19 vaccine Sputnik V in India with the first dose administered in Hyderabad. The imported vaccine under current pilot project has been priced at Rs 995.4/dose including 5% GST. Expecting second and further imported consignments in upcoming months, DRL said supply from Indian manufacturers will commence soon. DRL also hoped of probably cheaper price when local supplies begin… read-more
Courtesy: Times Of India
Dr. Reddy's Laboratories is expected to receive 250 million doses of Russian vaccine ‘Sputnik V’ between April and June. Reportedly, the supply will be determined by considering the number of doses requested by the Centre and the cold chain mechanism in place to deliver them throughout the country. While, currently, Sputnik is negotiating with the government regarding the price, India will use the Russian Direct Investment Fund for its… read-more
Courtesy: The Indian Express
The Indian subject expert committee on April 12, has approved the Russian Vaccine Sputnik V for the emergency use. This approval was made during the time of vaccine shortage in various states of the country. Partnered with Russian manufacturers, Dr. Reddy’s Laboratories will receive 100 million doses of the Sputnik V vaccine as agreed. Earlier, the expert committee sought information on Sputnik V vaccine clinical trials.
Courtesy: Deccan Herald
Pharmaceutical MNC Dr Reddy’s have applied for emergency use authorization of Russian COVID-19 vaccine ‘Sputnik-V’ in India. Showing 91.6% efficacy in the last-stage trials, the vaccine maker has assured to submit the test interim data by February 21. Produced by Moscow’s Gamaleya Institute and registered in almost 30 countries, the vaccine will be the most effective in India if approved. Reportedly, Reddy’s and Russian Development Investment… read-more
Courtesy: The Economic Times